A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity
Clinical trial NCT06084598 · COMPLETED
Trial details
- NCT number
- NCT06084598
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-12
- Primary completion
- 2024-03-08
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.